Barclays Reduces PT on BellRing Brands (BRBR) to $27, Reiterates An ‘Overweight’ Rating

Core Viewpoint - BellRing Brands, Inc. is currently identified as one of the oversold value stocks to consider for investment [1] Financial Performance - For fiscal Q1 2026, BellRing Brands reported net sales of $537.30 million, reflecting a 1% year-over-year increase [3] - Adjusted EBITDA decreased to $90.30 million from $125.30 million, and net income fell from $76.90 million to $43.70 million [3] - The growth in top-line sales was primarily driven by a 7.50% increase in Dymatize sales, although this was partially offset by a 2.20% decline in ready-to-drink (RTD) sales [3] - Gross margins contracted to 29.90% due to heightened whey costs and input inflation [3] Guidance and Projections - For the full fiscal year, the company projects net sales between $2.41 billion and $2.46 billion, indicating a growth of 4-6% [4] - Adjusted EBITDA is expected to be in the range of $425 million to $440 million, with capital expenditures estimated at $8 million [4] - The company anticipates accelerations in performance during the second half of the fiscal year [4] Analyst Insights - Barclays analyst Andrew Lazar has reduced the price target for BellRing Brands from $30 to $27 while maintaining an 'Overweight' rating [2] - This adjustment follows the company's management narrowing its fiscal 2026 net sales and adjusted EBITDA guidance amid increased promotional activities from competing protein shake brands [2]